ArticleCell death & disease2020

NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer.

Lili Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.